CATALYA

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.

Disruptive Pharma

This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.

Surf Bio

This company develops drug stabilisation and delivery platforms for pharmaceutical manufacturers to enable high-concentration subcutaneous administration of biologics and vaccines.

Cristal Therapeutics

This deep-tech company develops click chemistry reagents and nanoparticle delivery platforms for pharmaceutical and diagnostic partners in the life sciences industry.

Catena Biosciences

This deep-tech company develops protein conjugation technology and multi-payload conjugates to create targeted therapeutics for patients with oncology and autoimmune diseases.

Creasallis

This biotech company develops a technology that improves the penetration of antibody-based drugs into solid tumours for pharmaceutical and biopharmaceutical organisations.

CePep AB

This company develops cell-penetrating peptide delivery platforms for nucleic acid based therapeutics and drug discovery applications within the biotechnology and pharmaceutical industries.

Dogma Biotech

This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.